Concurrent low-dose radiation and durvalumab and etoposide/platinum shows promising efficacy in 1L ES-SCLC

Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer

Twice-daily chemoradiation remains the standard of care in limited stage small-cell lung cancer

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Optimising multiple myeloma care in Latin America

Global trends and inequalities in breast cancer survival and care

Multiple myeloma in a resource constrained setting

ASCO GU 2024: Latest in PARP inhibitors for prostate cancer

Updates on lung cancer from WCLC and ESMO 2023

Subcutaneous delivery of nivolumab is effective in treating metastatic ccRCC

Enfortumab vedotin in combination with pembrolizumab is a potential new standard of care for 1L la/mUC

Enzalutamide monotherapy prolongs MFS compared to leuprolide alone in men with high-risk biochemically recurrent PC